Molecules 2021, 26, 1227
23 of 24
36. Otsuki, T.; Yata, K.; Takata-Tomokuni, A.; Hyodoh, F.; Miura, Y.; Sakaguchi, H.; Hatayama, T.; Hatada, S.; Tsujioka, T.; Sato, Y.
Expression of protein gene product 9 5 (PGP9 5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Br. J.
37. Gu, Y.Y.; Yang, M.; Zhao, M.; Luo, Q.; Yang, L.; Peng, H.; Wang, J.; Huang, S.K.; Zheng, Z.X.; Yuan, X.H.; et al. The de-ubiquitinase
UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways. Tumor Biol. 2015, 36, 8379–8387. [CrossRef]
38. Liu, S.; González-Prieto, R.; Zhang, M.; Geurink, P.P.; Kooij, R.; Iyengar, P.V.; van Dinther, M.; Bos, E.; Zhang, X.;
Le Dévédec, S.E.; et al. Deubiquitinase activity profiling identifies UCHL1 as a candidate oncoprotein that promotes
TGFβ-induced breast cancer metastasis. Clin. Cancer Res. 2020, 26, 1460–1473. [CrossRef]
39. Jang, M.J.; Baek, S.H.; Kim, J.H. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Cancer Lett.
40. Ma, Y.; Zhao, M.; Zhong, J.; Shi, L.; Luo, Q.; Liu, J.; Wang, J.; Yuan, X.; Huang, C. Proteomic profiling of proteins associated with
lymph node metastasis in colorectal cancer. J. Cell. Biochem. 2010, 110, 1512–1519. [CrossRef]
41. Miyoshi, Y.; Nakayama, S.; Torikoshi, Y.; Tanaka, S.; Ishihara, H.; Taguchi, T.; Tamaki, Y.; Noguchi, S. High expression of ubiquitin
caboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci.
42. Goto, Y.; Zeng, L.; Yeom, C.J.; Zhu, Y.; Morinibu, A.; Shinomiya, K.; Kobayashi, M.; Hirota, K.; Itasaka, S.; Yoshimura, M.; et al.
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1
α. Nat. Commun. 2015, 6, 6153.
43. Kim, H.J.; Kim, Y.M.; Lim, S.; Nam, Y.K.; Jeong, J.; Kim, H.-J.; Lee, K.-J. Ubiquitin C-terminal hydrolase-L1 is a key regulator of
tumor cell invasion and metastasis. Oncogene 2009, 28, 117–127. [CrossRef]
44. Liu, Y.; Lashuel, H.; Choi, S.; Xing, X.; Case, A.; Ni, J.; Yeh, L.-A.; Cuny, G.D.; Stein, R.L.; Lansbury, P.T. Discovery of Inhibitors that
Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line. Chem. Biol. 2003, 10, 837–846. [CrossRef] [PubMed]
45. Panyain, N.; Godinat, A.; Lanyon-Hogg, T.; Lachiondo-Ortega, S.; Will, E.J.; Soudy, C.; Mason, K.; Elkhalifa, S.; Smith, L.M.;
Harrigan, J.A.; et al. Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating
enzyme UCHL1, with anti-fibrotic activity. J. Am. Chem. Soc. 2020. [CrossRef]
46. Krabill, A.D.A.D.; Chen, H.; Hussain, S.; Feng, C.; Abdullah, A.; Das, C.; Aryal, U.K.; Post, C.B.C.B.; Wendt, M.K.M.K.;
Galardy, P.J.; et al. Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-
47. Kattenhorn, L.M.; Korbel, G.A.; Kessler, B.M.; Spooner, E.; Ploegh, H.L. A Deubiquitinating Enzyme Encoded by HSV-1 Belongs
to a Family of Cysteine Proteases that Is Conserved across the Family Herpesviridae. Mol. Cell 2005, 19, 547–557. [CrossRef]
48. Davies, C.W.; Chaney, J.; Korbel, G.; Ringe, D.; Petsko, G.A.; Ploegh, H.; Das, C. The co-crystal structure of ubiquitin carboxy-
terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK). Bioorganic Med. Chem. Lett.
49. Powers, J.C.; Asgian, J.L.; James, K.E. Irreversible Inhibitors of Serine, Cysteine, and threonine proteases. Chem. Rev. 2002
.
50. Palmer, J. Process for Forming a Fluoromethyl Ketone. U.S. Patent No. 5,210,272, 11 May 1993.
51. Witte, M.D.; Descals, C.V.; De Lavoir, S.V.P.; Florea, B.I.; Van Der Marel, G.A.; Overkleeft, H.S. Bodipy-VAD-Fmk, a useful tool to
study yeast peptide N-glycanase activity. Org. Biomol. Chem. 2007, 5, 3690–3697. [CrossRef]
52. Morris, T.S.; Frormann, S.; Shechosky, S.; Lowe, C.; Laid, M.S.; Gauss-mfiller, V.; Purcell, R.H.; Emerson, S.U.; Vederas, J.C.;
Malcolm, B.A. In Vitro and Ex Vivo Inhibition of Hepatitis A Virus 3C Proteinase by a Peptidyl Monofluoromethyl Ketone. Bioorg.
53. Misaghi, S.; Pacold, M.E.; Blom, D.; Ploegh, H.L.; Korbel, G.A. Using a small molecule inhibitor of peptide: N-glycanaseto probe
its role in glycoprotein turnover. Chem. Biol. 2004, 11, 1677–1687. [CrossRef] [PubMed]
54. Hassiepen, U.; Eidhoff, U.; Meder, G.; Bulber, J.F.; Hein, A.; Bodendorf, U.; Lorthiois, E.; Martoglio, B. A sensitive fluorescence in-
tensity assay for deubiquitinating proteases using ubiquitin-rhodamine110-glycine as substrate. Anal. Biochem. 2007, 371, 201–207
.
55. Boudreaux, D.A.; Maiti, T.K.; Davies, C.W.; Das, C. Ubiquitin vinyl methyl ester binding orients the misaligned active site of the
ubiquitin hydrolase UCHL1 into productive conformation. Proc. Natl. Acad. Sci. USA 2010, 107, 9117–9122. [CrossRef] [PubMed]
56. Koharudin, L.M.I.; Liu, H.; Di Maio, R.; Kodali, R.B.; Graham, S.H.; Gronenborn, A.M. Cyclopentenone prostaglandin-induced
unfolding and aggregation of the Parkinson disease-associated UCH-L1. Proc. Natl. Acad. Sci. USA 2010, 107, 6835–6840.
57. Contu, V.R.; Kotake, Y.; Toyama, T.; Okuda, K.; Miyara, M.; Sakamoto, S.; Samizo, S.; Sanoh, S.; Kumagai, Y.; Ohta, S. Endogenous
neurotoxic dopamine derivative covalently binds to Parkinson’s disease-associated ubiquitin C-terminal hydrolase L1 and alters
its structure and function. J. Neurochem. 2014, 130, 826–838. [CrossRef] [PubMed]
58. Nakamura, T.; Oh, C.; Liao, L.; Zhang, X.; Lopez, K.M.; Gibbs, D. Noncanonical transnitrosylation network contributes to synapse
loss in Alzheimer’ s disease. Science (80-.) 2020, 0843, 1–18.